Application 077009
- Type
- ANDA
- Sponsor
- TARO
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ONDANSETRON HYDROCHLORIDE | ONDANSETRON HYDROCHLORIDE | SOLUTION;ORAL | EQ 4MG BASE/5ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50436-4091 | Ondansetron | ondansetron hydrochloride | Unit Dose Services | ANDA | Current |
| 51672-4091 | Ondansetron | ondansetron hydrochloride | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |
| 51672-4091 | Ondansetron | ondansetron hydrochloride | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |
| 68071-1649 | Ondansetron | ondansetron hydrochloride | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-1649 | Ondansetron | ondansetron hydrochloride | NuCare Pharmaceuticals,Inc. | ANDA | Current |